Guerbet SA (EPA:GBT)
10.36
+0.02 (0.19%)
Jun 3, 2026, 5:35 PM CET
Guerbet Market Cap
Guerbet has a market cap or net worth of €130.44 million as of June 3, 2026. Its market cap has decreased by -46.32% in one year.
Market Cap
130.44M
Enterprise Value
449.22M
Revenue
798.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
€10.36
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has decreased from 142.85M to 130.44M, a decrease of -8.68%. That is a compound annual growth rate of -0.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 130.44M | -27.61% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 219.49M |
| Median Technologies | 202.88M |
| Carvolix | 195.50M |
| Theraclion | 50.88M |
| Novacyt | 42.75M |
| Diagnostic Medical Systems | 32.50M |
| Implanet | 26.55M |
| Ikonisys | 25.35M |